ascopubs.org

Effect of G-CSF prophylaxis on the occurrence of neutropenia in men receiving cabazitaxel plus prednisone for the treatment of metastatic castration-resistant prostate cancer ...

Neoadjuvant trial of sunitinib malate and androgen ablation (ADT) in patients with localized prostate cancer (PCa) at high risk for recurrence. Background: The phase III TROPIC study showed that ...
Financial Post

Starton Therapeutics Phase 2 TROPIC-I Clinical Study will be First to Use Total Control Primary Endpoint in Superiority Study STAR-OLZ for acute and delayed chemotherapy ...

PARAMUS, N.J., June 16, 2021 (GLOBE NEWSWIRE) — Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company transforming standard of care therapies with proprietary ...
Finanznachrichten

Phase III Data Showing Improved Survival With Jevtana (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet / Results of the Phase III TROPIC ...

Results of the TROPIC study showed that the combination of Jevtana and prednisone significantly reduced the risk of death by 30% [HR=0.70 (95% CI: 0.59-0.83); P<0.0001], with an improvement in median ...